Showing results (321-330 of 375) with videos related to
Sort By:
Pageof 38
The Journal of Clinical Endocrinology and Metabolism|January 13, 2004
Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetesHelen L Simpson, Nicola C Jackson, Fariba Shojaee-Moradie, et al.Environmental Toxicology and Chemistry|December 2, 2017
Prospective aquatic risk assessment for chemical mixtures in agricultural landscapesChristopher M Holmes, Colin D Brown, Mick Hamer, et al.American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 23, 2008
Poly-immunoglobulin receptor-mediated transport of IgA into the male genital tract is important for clearance of Chlamydia muridarum infectionKelly A Cunningham, Alison J Carey, Jane M Finnie, et al.The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
Effects of growth hormone (GH) replacement therapy on low-density lipoprotein apolipoprotein B100 kinetics in adult patients with GH deficiency: a stable isotope studyE R Christ, M H Cummings, N Jackson, et al.Diabetologia|January 31, 2025
Comparison of continuous glucose monitoring with self-monitoring of blood glucose in type 1 diabetes in the changing atmospheric pressures in aviation: a hypobaric flight simulationKa Siu Fan, Antonios Manoli, Petra M Baumann, et al.The Journal of Pathology|March 13, 1998
HHV8 and female Kaposi's sarcomaM M Kennedy, S B Lucas, R Russell-Jones, et al.Climate Risk Management|August 25, 2020
Modeling Coastal Flood Risk and Adaptation Response under Future Climate ConditionsMark Lorie, James E Neumann, Marcus C Sarofim, et al.The Journal of Clinical Endocrinology and Metabolism|October 23, 2022
Effect of Dapagliflozin on Cardiac Function and Metabolic and Hormonal Responses to ExerciseRoselle A Herring, Iain Parsons, Fariba Shojaee-Moradie, et al.European Journal of Endocrinology|February 25, 2006
Low-density lipoprotein apolipoprotein B100 turnover in hypopituitary patients with GH deficiency: a stable isotope studyEmanuel R Christ, Michael H Cummings, Michael Stolinski, et al.Diabetes, Obesity & Metabolism|May 25, 2019
Glycaemic benefit of iGlarLixi in insulin-naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan-O randomized trialMelanie J Davies, David Russell-Jones, Thomas M Barber, et al.Pageof 38